healthcareanalysis-blog

[healthcareanalysis-blog]

Surgical Incision Closure Market Size, Analysis  and Forecasts to 2020

Surgical incision closure market is expected to register significant growth over the forecast period owing to increasing investment in research and development, reduced level of trauma along with reducing risks of infection, and increasing demand to shorten length of hospital stay. Appropriate incision closure during surgery is crucial to maintain integrity of tissues and regain normal functions. Primary objective during a surgery is to achieve hemostasis and to seal the incision both internally and externally. Any failure to seal the incisions perfectly leads to severe medical conditions such as infection and critical scarring. Introduction of technologically advanced incision closure products is additionally expected to propel growth of this market.

Surgical incision and closure market is segmented on three different bases such as type, application and products. On the basis of type market is divided into advanced wound care market and advanced wound closure market. Burns, ulcers and surgical wounds are the market types based on application. Sutures, tissue sealants and staplers are the three types on the basis of products. Sutures possess one of the highest market share and are expected to continue the dominance owing to the expansive product development efforts.

For more information on "Surgical Incision Closure Market Analysis” Visit: http://www.grandviewresearch.com/industry-analysis/surgical-incision-closure-market

For instance, recently developed barbed suture technology is designed to face challenging procedures such as endoscopic surgeries. Tissue sealants on the other hand is gaining market share steadily. Their demand is specially rising in case of cosmetic and minimally invasive surgeries. Surgical staplers continue to generate majority of sales. They have applications in many gynecologic, thoracic, and pediatric procedures but bariatric and emphysema market accounts for major share.

North America is expected to have the largest share due to higher consumer base of aesthetic surgeries, spinal fusion, and rising numbers of hip and knee replacement surgeries. Asia Pacific is expected to register a lucrative growth owing to improvement in healthcare infrastructure, rising spending in healthcare segment, new establishments of healthcare & diagnostic centers, and increased access to healthcare services.

Request TOC of “Surgical Incision Closure Market Analysiss" visit : http://www.grandviewresearch.com/industry-analysis/surgical-incision-closure-market/request-toc

[healthcareanalysis-blog]

Healthcare Analytics Market Analysis  and Segment Forecasts to 2024

The global healthcare analytics (HA) market is expected to reach USD 42.8 billion by 2024, according to a new report by Grand View Research, Inc. Efforts to reduce the spiraling healthcare costs is facilitating the usage of the healthcare analytics. Additionally, the benefits of HA include the improvement of patient access to customized care, the furthering of transparent operations to enable better public oversight, and innovation in patient care delivery and services.

Furthermore, analytics play a major part in striving to ameliorate the health economic efficiency. For instance, l’Assurance Maladie in France employed analytics to assess the clinical safety of the class of cholesterol-lowering drugs, statins, which have been implicated in causing severe side-effects, and the derived results were used to introduce evidence-based performance measures to address the cracks in the operational system

Predictive Analytics market estimates and trends

View summary of "Healthcare Analytics Market Analysis Report"  @ http://www.grandviewresearch.com/industry-analysis/healthcare-analytics-market

Further key findings from the study suggest:

Descriptive analytics held a significant share in 2015 owing to its applications in process optimization in organizations. On the other hand, predictive analytics is anticipated to grow at a lucrative rate over the forecast period mainly due to its wide applicability in medical systems, such as fraud prevention, disease prevalence forecasts, and risk assessment.

The services category dominated the component segment in 2015. Outsourcing of these big data services contributed towards their growth in leading to the high volume of services rendered. Moreover, the outsourcing of services helps in cutting costs associated with infrastructure requirements and in addition, avoids the requirement of skilled individuals to perform the same task.

The hardware systems category dominated the component segment, high-cost of the hardware, such as the use of computer systems and internet servers contributed to its growth.

On-premise delivered analytic services dominated the delivery mode category with around 54.0% share in 2015. However, the cloud-based delivery mode segment is anticipated to grow at a profitable rate over the forecast period. The benefits of the cloud system, which include remote data entry and real-time data entry features are expected to result in the growth of this segment.

The applications of the healthcare big data include financial applications, operational & administrative applications, and clinical applications. Operational and administrative applications governed the applications segment and held a remunerative share in the year, 2015.

The demand for financial applications is anticipated to boost over the forecast period. These applications include payment and claim settlements and fraud prevention and risk analysis. Various initiatives undertaken by the government, such as the Fraud Prevention System (FPS) from the CMS is promoting its adoption.

The end-users of HA include payers, providers, and others. Payers held a significant market share in 2015 and the providers are anticipated to grow at a lucrative rate. The usage of these services by providers is for population health management, quality improvement, and personalized care.

North America captured a significant share in the global market. Advanced healthcare infrastructure in this region and the growing per capita healthcare expenditure supported the greater consumption of these services.

The Asia Pacific region is expected to witness gainful growth attributable to the untapped opportunities in the countries including India and China.

Some key players operating in the healthcare analytics market include IBM Corporation, Oracle Corporation, SAS, Cerner Corporation, Allscripts Healthcare Solutions, Inc., Optum Health, Inc., and Verisk Analytics, Inc. The notable initiatives in the industry include new product launches, collaboration with government bodies, and investments directed towards R&D efforts.

For instance, in December 2015 Truven Health Analytics, Inc. and Philips Electronics N.V. integrated Truven Health Micromedex Solutions in the management platform, the Tasy System. This integrated platform is anticipated to facilitate fast and easy access to a wealth of evidence-based medical information present in the drug interaction repositories of Micromedex Solutions.

Request for free sample of "Healthcare Analytics Market Analysis Report" @ http://www.grandviewresearch.com/industry-analysis/healthcare-analytics-market/request

[healthcareanalysis-blog]

Laboratory Filtration Market Analysis, Size and Growth to 2024

The laboratory filtration market is expected to reach USD 3.6 billion by 2024, according to a new report by Grand View Research, Inc. The increasing number of target diseases such as water-borne diseases, immunodeficiency diseases, and cancer is anticipated to boost the market growth. The increasing use of filtration technologies such as microfiltration, nanofiltration, and ultrafiltration in water purification plants is expected to enhance growth in this sector.

Technological advancements in filtration products have resulted in an increase in the adoption rate of these products in clinical laboratories for research purposes. The products introduced provide benefits such high reliability, competency, and high throughput over the conventional methods. For instance, Merck Millipores millex syringe filters filter small-volume filtrates and these filters are ideally used for antibiotics and tissue culture additives.

U.S. Laboratory Filtration Market by Product, 2013 - 2024 (USD Million)

View summary of "Laboratory Filtration Market Analysis Report"  @ http://www.grandviewresearch.com/industry-analysis/laboratory-filtration-market

Further Key Findings From the Study Suggest:

The filtration media segment dominated this market in 2015, with a revenue share of over 40%.The large share is attributed to its cost-effective nature, higher efficiency, and reliability for industrial bioprocessing.

Microfiltration assemblies dominated the assembly segment in 2015. Some of the benefits associated with microfilters such as easier availability, portability, and easier disposal make them the highly preferred technology.

The microfiltration technology segment held the largest share in 2015, owing to the increasing application of microfiltration in industrial biotechnology and associated research.

North America dominated the overall market with a revenue share of over 42% in 2015, owing to the presence of well-equipped laboratories for life science research, increasing investments in R&D, and the presence of government funding programs for laboratory filter membrane business owners.

Asia Pacific is anticipated to be the fastest growing region with a CAGR of over 8.3%in the forecast period.Factors such as economic development, untapped market opportunities, new emerging market, and advancing healthcare system with the aid of supportive government initiatives are anticipated to assist in growth.

The presence of major market players enhances the penetration of laboratory filtration product in the market. Some of the key players are Merck Millipore, Sigma-Aldrich, GE Healthcare, Thermo Fisher Scientific, Sartorius Group, 3M Company, Cantel Medical Corporation, Macherey-Nagel Gmbh& Co. Kg.

The key players are entering into collaborations such as mergers and acquisitions with other key players to increase their market share. For instance, in November 2015, Merck Millipore acquired Sigma-Aldrich to enhance its life science segment, and this business segment based in the U.S. is named as MilliporeSigma.

Request for free sample of "Laboratory Filtration Market Analysis Report" @ http://www.grandviewresearch.com/industry-analysis/laboratory-filtration-market/request

[healthcareanalysis-blog]

Single Cell Analysis Market Analysis, Size and Growth to 2024

The global Single Cell analysis market is expected to reach USD 5.0 billion by 2024, according to a new report published by Grand View Research, Inc. The rising adoption of Single Cell analysis tools owing to the improving healthcare scenario is fueling the growth of the market.

The continuous efforts in the R&D sector of the healthcare industry are resulting in the wide applicability of the Single Cell analysis technologies in the different disease areas, as a widespread diagnostic tool to address the complex heterogeneity observed in cells. Introduction of stem cell therapies and non-invasive techniques for prenatal analysis are some of the examples of the applications of the Single Cell analysis techniques. On the contrary, the high-cost and long shelf-life of the instruments is challenging the growth of the market.

The extensive demand for non-invasive techniques for prenatal diagnosis to prevent the immunological and genetic disorders in fetuses is fueling the demand for Single Cell tests in the market. The penetration of advanced therapeutic tools for the treatment of chronic diseases, such as cancer related to the malfunctions of the Single Cells is proving to be a boon for the global market. Moreover, the adoption of stem cell therapy for treatments related to bone marrow transplants, hair regeneration, and other health-related issues is widening the scope of the Single Cell analytical technologies globally.

Geographically, the market has been segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa (MEA). North America accounted for the largest market share and was followed by Europe in 2015.Well-developed healthcare and R&D infrastructure and the availability of skilled labor are pushing the adoption of Single Cell analysis in these regions.

AsiaPacificis expected to show the fastest growth rate during the forecast period. Factors, such as the booming medical tourism, availability of advanced healthcare treatments, and the availability of skilled healthcare professionals at a lower cost are some of the factors anticipated to accelerate the adoption of Single Cell analysis in the Asia Pacific region. Moreover, the increasing government expenditure for clinical research activities and the improvement of healthcare infrastructure are boosting the growth of the market. As a result, the Asia Pacific market is anticipated to capture around 21% of the global share during the forecast period.

China Single Cell Analysis Market, by Instrument type, 2014 - 2024 (USD Million)

View summary of "Single Cell Analysis Market Analysis Report"  @ http://www.grandviewresearch.com/industry-analysis/single-cell-analysis-market

Further key findings from the study suggest:

The consumables segment accounted for the largest market share and is expected to maintain its dominance owing to the repeat purchase of reagents, assay kits, beads, and microplates

The instruments market segment is expected to show significant growth during the forecast period

The applications segment of the market is further divided into cancer, neurology, immunology, prenatal diagnosis, and in-vitro fertilization. Increasing prevalence of the target diseases is propelling the growth of the market.

North America captured the largest market share of around 38% in 2015 and is estimated to maintain its dominance throughout the forecast period. Speedy adoption of analytical techniques and the rising R&D efforts in the field of diagnostics are the major factors contributing to the largest market share of North America in the global market. The AsiaPacific region is expected to show significant growth from 2016 to 2024 due mainly to the flourishing clinical research sector, medical tourism, and the high government healthcare expenditure in the region.

The major market players in this market include but are not limited to Thermo Fisher Scientific, Inc., Illumina, Inc., Qiagen N.V., Bio-Rad Laboratories, Inc., Merck Millipore GmbH, Beckman Coulter, Inc. (U.S.),Becton, Dickinson and Company (U.S.)

Request for free sample of "Single Cell Analysis Market Analysis Report" @ http://www.grandviewresearch.com/industry-analysis/single-cell-analysis-market/request

[healthcareanalysis-blog]

Patient Portal Market Analysis, Size and Growth to 2024

The global patient portal market is expected to reach USD 5.2 billion by 2024, according to a new report by Grand View Research, Inc. The demand for Electronic Health Record (EHR) with a patient portal is expected to exhibit an upsurge over the forecast period, owing to the increasing demand, favorable government funding policies, and the continual technological advancements offered by the key industrial players.

In May 2016, CureMD signed a pledge of Voluntary National Interoperability. This pledge stated that action plans to develop and implement rapid flow in healthcare information between providers, patients, and other concerned authorities are to be implemented.

U.S. patient portal market, by type, 2013 –2024 (USD Million)

View summary of "Patient Portal Market Analysis Report"  @ http://www.grandviewresearch.com/industry-analysis/patient-portal-market

Further Key Findings From the Report Suggest:

Integrated Patient portal was identified as the most lucrative segment in 2015. The rapid shift of providers from their previous methods to the EHRs, advancements in technology, and increasing demand were some of the reasons for its largest market share.

In June 2015, ICON (a global drug development and service provider) launched its online “Firecrest Patient Portal” It was specifically designed for a person to understand the entire treatment process before consulting the provider and view information regarding clinical trials.

Moreover, this provided services such as online appointment registration, laboratory tests and reports, and other necessary facilities.

Also, as per a report by the European commission, 11regions across the European Union (EU) had participated in the “Sustains project” since 2012, which was EU sponsored. This project was an initiative for joint learning, providing patients’ access to their health records and other online services.

North America dominated the market in 2015 as a result of the technological advancements and implementation of healthcare IT in the region.

In June 2014, Brattleboro Memorial Hospital launched “myHealthPortal.” It is expected to provide easy and early access to the selected portions of the health records. It is safe and secure, providing confidential communication between the providers and the patient.

Europe is expected to grow at a higher rate over the forecast period due to increasing demand of efficient healthcare delivery and advanced solutions. Increased government initiatives in the region and deployment of EHR-based portal solutions are considered responsible for its high growth rate.

In November 2015, an event was organized in the European Parliament by members of the European Parliament, Health Policy Partnership, Lung Cancer Europe, and European Cancer Patient’s Coalition. This event witnessed the launch of an Immuno-oncology Patient Portal that proved to be a unique solution for people suffering from cancer in Europe.

Developers are collaborating and expanding with the aim of combining the use of innovation and technology to improve efficiency and provide better services for the convenience of the providers.

In 2016, McKesson Corporation announced a partnership with Blue Cross Blue Shield of Arizona. This partnership will help deliver a broad range of services, thereby assisting the service providers.

In 2015, GE Healthcare announced the acquisition of Camden Group in order to provide their clients access to analytics that involves change management and activation resources, which support organizational and clinical changes.

Some key players in this market are GE Healthcare, Allscripts Healthcare Solutions, McKesson Corporation, and Cerner Corporation.

Request for free sample of "Patient Portal Market Analysis Report" @ http://www.grandviewresearch.com/industry-analysis/patient-portal-market/request

[healthcareanalysis-blog]

Vein Illuminator Market Analysis and Segment Forecast to 2024

The global vein illuminator market is expected to reach USD 358.5 million by 2024, according to a new report published by Grand View Research, Inc. The vein illuminator market is anticipated to witness a lucrative growth during the period 2016 to 2024. The factors contributing towards the growth of the market are the growing aging population and the efforts channelized towards improving patient satisfaction. Additionally, factors, such as the demand for technologically advanced medical equipment and the rising research and practical applications are expected to be opportunistic for the industry growth. However, the prevalence of traditional methods owing to the high costs of the vein illuminator devices is likely to hinder the growth of the market in the near future.

The vein illuminator market is segmented on the basis of technology, application, end-user, and region. Based on technology, the market is further categorized into transillumination, infrared technology, and ultrasound. The near-infrared illumination technology is estimated to be the largest shareholder due to its ability to penetrate deep into the tissue, which makes it possible to visualize the vessels clearly.

On the basis of application, the market is segmented into intravenous access and blood draw. The end-user segment comprises hospitals, rehabilitation facilities, blood donation camps, and academic institutions. The market for hospitals is expected to grow rapidly during the forecast period due to a surge in the demand for technologically advanced medical equipment. The market is also categorized into North America, Europe, Asia Pacific, MEA, and Latin America.

Vein Illuminator Market, by End-user, 2013 - 2024 (USD Million)

View summary of "Vein Illuminator Market Analysis Report"  @ http://www.grandviewresearch.com/industry-analysis/vein-illuminator-market

Further key findings from the study suggest:

In terms of market share, the North America vein illuminator market is expected to hold majority of the share in 2016. Factors resulting in the growth of this industry are the steady preference for highly-advanced medical devices by hospitals as well as the presence of several medical device manufacturing companies in the region.

The infrared illumination technology is estimated to lead the industry due to its deep penetration capability into thick tissues tohighlight the presence of vessels with increased clarity. Based on application, the segment for intravenous access is estimated to be the largest shareholder, followed by the blood draw segment.

The vein illuminator industry comprises several local as well as global players. Some prominent players in this industry include Accuvein, Inc., Christie Medical Holdings, Inc., Infrared Imaging Systems, Inc., Translite, LLC, and Venoscope, LLC,among others. In order to hold a major share in the industry, the companies are adopting both organic as well as inorganic strategies. The major strategies adopted by the companies are new product development, mergers, collaborations, partnerships, geographical expansions, and acquisitions.

The companies are also focusing on research and development activities in order to enhance their product portfolio. For instance, in September 2015, Accuvein, Inc., declared its 26th patent, which was issued by the United States Patent and Trademark office for their vein visualization system.

Request for free sample of "Vein Illuminator Market Analysis Report" @ http://www.grandviewresearch.com/industry-analysis/vein-illuminator-market/request

[healthcareanalysis-blog]

Electronic Health Records (EHR) Market Analysis, Size and Growth to 2022

Global electronics health records (EHR) market size was estimated USD 19.96 billion in 2014 and the market is expected to grow at a CAGR of 5.2% over the forecast period. Quality improvements of healthcare services owing to the implementation of advanced technology tools, rising importance of granting the patients access to critical medical information, and improving their safety concerns are few of the driving factors for the significant increase in the electronic health records market.

Global EHR market is anticipated to value worth USD 29.81 billion by 2020.Electronic health records are a consolidated report storing a wide range of information like the laboratory test results, demographics, diagnostic images, medical history of patients and medications provided. Their ability to provide up-to date and accurate patient information, reduced medical errors, increased patient participation, reduced healthcare cost and improved efficiency are major factors driving the EHR market demand.

North America EHR market revenue by product, 2012 - 2022, (USD Million)

View summary of "Electronic Health Records (EHR) Market Analysis Report"  @ http://www.grandviewresearch.com/industry-analysis/electronic-health-records-ehr-market

Increased usage of tablets and smartphones has augmented the EHR market demand as well. Patient records could be easily managed with reduced human errors by implementing the EHR software to record the medical history of patients giving traceability and ease operation. Favourable government policies like the American Recovery and Reinvestment Act (ARRA) is expected to support the growth of EHR market.

On the basis of product, the EHR market is segmented into web or cloud-based and client-server based. Web-based EHR market has accounted the largest product segment and accounts for over USD 16.00 billion in 2014. Client-server based EHR systems mostly store in-house data. They need hardware, software and a server to be installed.

Cloud-based EHR have the advantage over client server based systems as they store information on external servers and web access is possible via a platform and a web service. Web based EHR market is expected to significantly grow at a CAGR of 5% owing to the lucrative benefits of ease of interoperability, no cost of maintenance of licensing and little investments in infrastructure.

On the basis of end use and application, market subsegments of EHR market are hospital use and ambulatory use. However, the ambulatory sub segment is further sub-segmented into stand-alone facility, clinical use and retail pharmacy use. As of 2014, hospital use shared the largest revenue due to increasing need for medication & consulting, optimum services and growing competition.

As of 2014, North America accounted for the largest share over USD 9.5 billion and a government law providing USD 64,000 from Medicare and Medicaid to every medical practitioner adopting EHR systems. Rising demand for improved quality of medical services, increased pressure for healthcare cost containment, and encouragement through government funding are some of the major factors for North America electronic health record market growth.

In 2014, Europe also shared profit in terms of revenue owing to the various development activities by prominent players of the EHR market. An Epic system was installed at Cambridge University Hospitals NHS Foundation Trust, in the UK, costing USD 214 million, in October 2014.

Emerging economies like India, China, Mexico, Brazil and South Africa are expected to demonstrate high economic growth and reflect immense potential for EHR market especially due to rising health awareness among the rising population and increasing disposable income.

Significant players in the EHR market are Siemens Medical Solutions,GE Healthcare, MEDITECH, McKesson Corp., and NextGen Healthcare.

Request for free sample of "Electronic Health Records (EHR) Market Analysis Report" @ http://www.grandviewresearch.com/industry-analysis/electronic-health-records-ehr-market/request

[healthcareanalysis-blog]

Computational Biology Market Analysis, Size and Growth to 2020

The Global Computational Biology Market is expected to reach USD 4,285.1 million by 2020 growing at a CAGR of 21.1%, according to a new study by Grand View Research, Inc. Steady increase in the usage & application of computational biology for bioinformatics R&D programs designed for sequencing genomes to better understand biological systems and increasing number of clinical studies in pharmacogenomics and pharmacokinetics for novel drug discovery studies are expected to drive computational biology demand over the next six years.

Computational genomics for cellular and biological simulation applications dominated the market in 2013, accounting for over 47% of global revenue. Key factors driving demand for these applications include the growth of drug designing, disease modeling and personalized medicine applications and the growing usage of computational biology for functional and structural genomics, epigenomics and metagenomics for the analysis of protein transcription, protein-protein interactions, gene sequencing and expression and 3-dimensional protein structure analysis.

View summary of "Computational Biology Market Analysis Report"  @ http://www.grandviewresearch.com/industry-analysis/computational-biology-market

Further key findings from the study suggest:

North America was the largest regional market, accounting for 58.0% of the global revenue in 2013. Its large share is majorly attributed to the growing research investments and initiatives for development of drug discovery, disease modeling technologies and innovations in biological computation methods. It is expected that Asia Pacific will witness the fastest growth in the market, at an estimated CAGR of 28.0% owing to the increasing expenditure in clinical studies for pharmacokinetics and pharmacogenomics.

The application of computational biology in proteomics for cellular simulation is expected to grow at the fastest CAGR of over 22% owing to the shift in sequencing studies towards further analysis of the nature of various biological proteins as a part of development of personalized medicine.

Drug discovery and disease modelling applications dominated the market, accounting for 58.0% of global revenue in 2013. This large share is attributed by the extensive drug development pipelines present for a number of global branded and generic drug manufacturing firms such as Sanofi, Novo Nordisk and Eli Lilly.

Computational Biology databases dominated the tools segment and accounted for 44.5% of the market revenue in 2013, owing to extensive genomic database usage for warehousing and data mining of biological and sequential data generated from genomic and proteomic studies. Consequentially, the software and services for the analysis of biological data is expected to witness the fastest CAGR of over 21.0%.

Key players of this market include Schrodinger, Accelrys, Certara, Entelos, Simulation Plus and others.

Request for free sample of "Computational Biology Market Analysis Report" @ http://www.grandviewresearch.com/industry-analysis/computational-biology-market/request

About Grand View Research Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact: Sherry James Corporate Sales Specialist, U.S.A. Grand View Research, Inc. United States Phone:  1-415-349-0058 Toll Free:  1-888-202-9519 Email:  sales@grandviewresearch.com Website: Grand View Research

[healthcareanalysis-blog]

Clinical Diagnostics Market Size, Analysis and Growth to 2022

Development of sophisticated and specialized tests for early disease detection and disease management and increasing demand for lab automation are the key drivers of clinical diagnostics market. The rapidly rising use of point of care diagnostic products has introduced a decentralization trend in the healthcare industry. Patients and healthcare facilities in an attempt to encourage early diagnosis, to cater medical facilities remotely and curb costs are now decentralizing their facilities. A wide array of clinical tests facilitate healthcare specialists the ability to detect disease progression which also include blood and urine test ranging from simple to complex, molecular expression genetic analysis and various medical chemistry panels.

For more information on "Clinical Diagnostics Market Analysis” Visit: http://www.grandviewresearch.com/industry-analysis/clinical-diagnostics-market

The global laboratory test market is expected to grow at a lucrative rate through the forecast period. Diagnostics market is segmented into clinical laboratory testing market and point-of-care testing. There are more than 4,000 different diagnostic tests available today and have been divided into lipid panel, complete blood count, HbA1c tests, HGB/HCT, BUN creatinine, liver panel, electrolytes testing, basic and comprehensive metabolic and renal panel tests. Lipid panel test is anticipated to be the fasted growing segment due to high prevalence of obesity and cholesterol related disease. Point of care diagnostics market is expected to show a significant growth rate during the forecast period owing to the growing geriatric population base, the ability of point of care diagnostic tests to render immediate results and hence improved patient care and rising market penetration of PACS (picture archiving and communication systems) and EMR (electronic medical records).

Global clinical diagnostic laboratory testing market is segmented into four major regions namely North America, Europe, Asia Pacific, Latin America and MEA. North America held the largest market share in terms of revenue owing to  increasing geriatric population base, rising patient awareness towards value of laboratory tests, availability of cost effective diagnostic tests related to chronic diseases such as AIDS and hepatitis C. Growing demand for the healthcare services in emerging markets and the presence of high unmet clinical testing needs have resulted in development of lucrative opportunities for growth of laboratory testing market in emerging economies such as China and India.

Request TOC of “Clinical Diagnostics Market Analysis" visit : http://www.grandviewresearch.com/industry-analysis/clinical-diagnostics-market/request-toc

About Grand View Research Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact: Sherry James Corporate Sales Specialist, U.S.A. Grand View Research, Inc. United States Phone:  1-415-349-0058 Toll Free:  1-888-202-9519 Email:  sales@grandviewresearch.com Website: Grand View Research

[healthcareanalysis-blog]

Biological Seed Treatment Market Size, Analysis and Growth to 2020

The global biological seed treatment is expected to grow at a considerable rate throughout the forecast period owing to their inherent prefer ability over other pest control methodologies. The rising global food requirements, encouraging government policies towards microbial products and growing demand for organic and environment friendly products are some of the major drivers expected to drive demand for this market. The overall increase in quality of agricultural produce as a consequence of using organic seed treatment is also expected to attract demand for biological seed treatment market.

The primary segmentation of this market is achieved by dividing the biologically treated seeds by their crop type which segments them into oilseeds & pulses, grains & cereals, vegetables & fruits. Some of the other types of crops included in the market are forage, turf, plantation and ornamental crops. Owing to the high market demand present for grains and cereals, the largest share of the market is accounted for by this segment. A treatment type-wise segmentation of the market includes microbial treatments and botanical treatments where microbial would use bacteria and fungi among others. Owing to their better environment friendly characteristics, relative cost effectiveness as compared to fertilizers, ease in management of residue is the primary drivers for the growth of this segment over the forecast period.

For more information on "Biological Seed Treatment Market Analysis” Visit: http://www.grandviewresearch.com/industry-analysis/biological-seed-treatment-market

In 2013, the largest market was observed to be dominated by North America. Due to the presence of technologically advanced agriculture practices and high yielding farming techniques and equipments, it is expected that over the coming six years the global biological seed treatment market is going to be dominated by this region. In terms of usage rates for these treated seeds, agricultural segments of Europe are second only to North America and are expected to grow at a considerable rate through to 2020.

With h the presence of a large population base and increasing technological developments in the emerging economies of India and China, it safe to expect that the most lucrative growth of this market can be expected for the Asia Pacific region. The major participants in the biological seed treatment market are Bayer CropScience AG, Valent Biosciences Corp., Italpollina,S.p.a., Arysta LifeScience Ltd., BASF SE, Monsanto, Syngenta AG, Koppert B.V. and Novozymes.

Request TOC of “Biological Seed Treatment Market Analysis" visit :http://www.grandviewresearch.com/industry-analysis/biological-seed-treatment-market/request-toc

[healthcareanalysis-blog]

Medical Sensors Market Analysis and Segment Forecasts to 2024

The medical sensors market is expected to reach USD 18.5 billion by 2024, according to a new report by Grand View Research, Incite upsurge in the number of patients afflicted with chronic conditions, such as diabetes and hypertension, is fueling the usage of monitoring as well therapeutic devices, thus boosting the market demand.

The target population for this market is patients with chronic illnesses, as such conditions necessitate regular checkups and intermittent or continuous patient monitoring. The rise in population of chronically ill patients further increases the uptake of the medical sensors.

The geriatric population is highly prone to developing chronic disorders and they pose a higher risk of developing age-related deformities and complications. Moreover, the adoption of unhealthy food habits and sedentary lifestyles and the resultant surge in the incidence of obesity has led to the increasing prevalence of lifestyle disorders including diabetes.

The medical sensors market is expected to reach USD 18.5 billion by 2024, according to a new report by Grand View Research, Incite upsurge in the number of patients afflicted with chronic conditions, such as diabetes and hypertension, is fueling the usage of monitoring as well therapeutic devices, thus boosting the market demand.

The target population for this market is patients with chronic illnesses, as such conditions necessitate regular checkups and intermittent or continuous patient monitoring. The rise in population of chronically ill patients further increases the uptake of the medical sensors.

The geriatric population is highly prone to developing chronic disorders and they pose a higher risk of developing age-related deformities and complications. Moreover, the adoption of unhealthy food habits and sedentary lifestyles and the resultant surge in the incidence of obesity has led to the increasing prevalence of lifestyle disorders including diabetes.

North America medical sensors market share, by product, 2013-2024 (USD Million)

View summary of "Medical Sensors Market Analysis Report"  @ http://www.grandviewresearch.com/industry-analysis/medical-sensors-market

Further key findings from the study suggest:

The biosensors products segment held a lucrative share of over 40.0% in 2015. This is ascribable to the following attributes of the novel biosensors: durability, reliability, and accuracy. Moreover, their applications in the healthcare areas, such as the detection of drug abuse, glucose monitoring for diabetes, the detection of cholesterol, and others. All these elements governed the growth of this segment in 2015.

The surgical applications of the sensors dominated the market in 2015. Whereas, the monitoring applications segment is projected to be the fastest growing during the forecast period. Advancements, such as wearable technology are anticipated to boost the demand for the monitoring devices market.

The hospitals registered a remunerative growth in 2015; this can be attributed to the presence of a well-developed healthcare infrastructure, which yields faster and accurate diagnosis. Moreover, the availability of well-equipped infrastructure coupled with the presence of skilled personnel and technologically advanced equipments contribute towards the lucrative growth of this segment.

North America held a considerably large share of over 35.0% in 2015 owing to the presence of leading sensor manufacturers, a well-planned medical reimbursement network, and the increasing disposable income

On the contrary, Asia Pacific is anticipated to be the fastest growing region with a CAGR of over8.0% over the forecast period. The favorable economic developments and the advancing healthcare system with the aid of supportive government initiatives are anticipated to further assist the growth. Moreover, the increasing base of the aging population in this region also, additionally impels the demand. According to the report published by the Ministry of Statistics, in India, 8.6% of the total population is aged above 60; hence, presenting a profitable opportunity for the market players to invest in this region.

The leading players of the medical sensors market include Analog devices, Inc., Avago technologies Ltd., Danaher Corporation, GE Measurement &Control Solutions, Inc., Honeywell International, Inc., Stellar technologies, Inc., OmniVision Technologies, Inc., Sensation AG, TE Connectivity Ltd., Micro-Epsilon Messtechnik GmbH Co. & KG, and NXP Semiconductors N.V.

Request for free sample of "Medical Sensors Market Analysis Report" @ http://www.grandviewresearch.com/industry-analysis/medical-sensors-market/request

[healthcareanalysis-blog]

Medical Suction Devices Market Analysis, Size and Growth to 2024

The global medical suction devices market is expected to reach USD 1.04 billion by 2024, according to a new report by Grand View Research. The global medical suction devices market is expected to grow swiftly owing to the increasing prevalence of chronic respiratory diseases, such as chronic obstructive pulmonary diseases, asthma, and lung cancer. Additionally, the market is growing rapidly due mainly to the increasing adoption of suction pumps in the point-of-care facilities. Moreover, the availability of compact suction devices has fostered the usage of these devices in ambulatory and emergency centers.

The government bodies including Ministry of Health and Family Welfare (MOHFW), Central Drugs Standard Control Organization (CDSCO), and Association of Indian Medical Device Industry (AIMED) provide the medical devices sector with a regulatory structure to promote indigenous production. Such regulations are positively impacting the market. Moreover, the increasing number of collaborations undertaken by companies, such as Drive Medical, Olympus Corporation, Laerdal Medical, with the aim of introducing technologically-advanced and improved devices is further boosting the growth of the market.

Medical Suction Devices Market, by Region, 2014 - 2024 (USD Million)

View summary of "Medical Suction Devices Market Analysis Report"  @ http://www.grandviewresearch.com/industry-analysis/medical-suction-devices-market

Further key findings from the study suggest:

The non-portable segment is anticipated witness lucrative growth during the forecast period owing to the increasing number of surgical procedures and the high price of the devices. As a result, this segment is projected to grow at the highest CAGR from 2016 to 2024.

The upsurge in the number of hospitals, clinics, and other healthcare facilities is propelling the demand for non-portable aspiration devices

The electrically powered vacuum systems segment captured the largest market share in 2015.The large market share of the segment was attributed to the widespread awareness and adoption of these devices in surgical settings.

The portable segment is expected to show rapid growth during the forecast period owing to the rising adoption of home healthcare services where portable and user-friendly medical devices are in demand

North America captured the largest market share of around 30% in 2015. Some factors contributing to the dominance of the segment include the presence of well-established healthcare infrastructure, existence of the leading market players, and the easily attainable approval for the class I devices by the U.S. Food and Drug Administration (FDA)

Asia Pacific is identified as the fastest growing market for medical suction devices. The factors including a large number of untapped customers, the growing trends in the adoption of the technically-advanced devices, and the expected rise in the target patient population are anticipated to drive the growth of the market.

Request for free sample of "Medical Suction Devices Market Analysis Report" @ http://www.grandviewresearch.com/industry-analysis/medical-suction-devices-market/request

[healthcareanalysis-blog]

Ventricular Assist Device Market Analysis, Size and Growth to 2022

The global ventricular assist device market is expected to reach USD 1.97 billion by 2022, according to a new report by Grand View Research, Inc. Key factors attributing to its rapid growth include rising prevalence of cardiovascular disorders coupled with the development of technological advanced products such as miniature device with infection reduction technology.

Furthermore, increasing healthcare expenditure, favorable reimbursement policies and advanced technological facilities, are expected to positively reinforce ventricular assist device market growth over the next seven years.

Ventricular assist device market is segmented on the basis of type of product which includes left ventricular, right ventricular and bi-ventricular assist device. Key factors attributing to rapidly increasing number of patients with end stage heart failure and low availability of therapeutic options are among the key factors attributing to the market growth.

With continual shortage of organ donors and increasing demand of LVADs’ for bridge to transplantation in patients suffering from end stage heart failure, is expected to positively reinforce market growth over the forecast period.

Technological advancements in VADs have been a continuous process since the launch of first generation device. First generation VADs are referred to as pulsatile volume displacement pumps which are powered by pneumatic or electrical drive systems. Some of the U.S. FDA approved products are the Abiomed BVS5000, Worldheart Novacor System (LVAS).

Second generation ventricular assist device which are usually known as continuous flow LVADs were developed to overcome several limitations of the pulsatile displacement systems. At present, second generation LVADs that are available include the TandemHeart pVAD, Thoratec Heartmate II, Jarvik 2000, and the Impella Pump System.

Third generation ventricular assist device such as VentrAssist, DuraHeart, HeartMate III LVAD and others are currently under various stages of development, clinical trials and commercialization stages. These third generation ventricular assist device are continuous flow device with more advancement in product design, materials, battery capacity and size. Constant development in these devices serves as a high impact rendering driver for the growth of the market.

U.S. ventricular assist device market, by product, 2012-2022, (USD Million)

For more information on "Ventricular Assist Device Market Analysis” Visit: http://www.grandviewresearch.com/industry-analysis/ventricular-assist-devices-market

Further key findings from the report suggest:

In 2014, North America accounted for largest market share of over55%. Key factors attributing to its large share include presence of advanced healthcare infrastructure, and high level of collaboration between various stakeholders including medical fraternity, medical device industry, regulatory authorities, universities and others.

Furthermore, presence of high research expenditure by public and private entities in healthcare sector is anticipated to propel market growth for ventricular assist device in the coming seven years.

Asia Pacific is expected to be one of the fastest growing markets, growing at a CAGR of over17% during the forecast period. Key factors attributed to the growth are high economic growth in countries such as China, Brazil, India, and South Korea coupled with high unmet medical needs is expected to boost usage rates of ventricular assist device.

Key players operating in ventricular assist device market include Abiomed, HeartWare International, Thoratec, Inc., Berlin Heart, Cardiac Assist and ReliantHeart

Request for free sample of "Ventricular Assist Device Market Analysis" @ http://www.grandviewresearch.com/industry-analysis/ventricular-assist-devices-market/request

About Grand View Research Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact: Sherry James Corporate Sales Specialist, U.S.A. Grand View Research, Inc. United States Phone:  1-415-349-0058 Toll Free:  1-888-202-9519 Email:  sales@grandviewresearch.com Website: Grand View Research

[healthcareanalysis-blog]

Ingestible Sensors Market Analysis, Size and Growth to 2024

Ingestible sensors market is expected to reach USD 2.0 billion by 2024, according to a new report by Grand View Research, Inc. The escalation in the geriatric population has driven the demand for improved, minimally-invasive, medical technologies and devices to address the needs of the elderly population subset. With the advent of the sensors that can be ingested, the internal anatomy of the human body can be easily studied and monitored with changes in pressure, temperature, and pH recorded constantly.

The internal anatomy can also be captured with the help of an image sensor, enabling enhanced visualization of the gastrointestinal tract along with any anomalies that maybe causing digestive perturbations; thus, expediting conclusive disease diagnosis with greater clarity while obviating cumbersome procedures, such as endoscopy.

The growing number of chronic diseases like cardiac diseases, obesity and diabetes along with cancer require constant physiological monitoring of vital bodily functions, which is easily met by the use of ingestible sensors. Favorable reimbursement options provided by governments and insurance companies have promoted the adoption of these devices to a larger extent. Compliance with medication regimes has increased significantly in patients, which has further encouraged the adoption of these ingestibles.

The medical vertical has been the highest gaining segment owing to the use of ingestible sensors in clinics and hospitals. These sensors furnish medical professionals with accurate, real-time data for multiple parameters through non-invasive and wireless technology; in consequence, these devices are a mainstay of diagnostic procedures. In other segments including sports and fitness, the wearable sensors that monitor vital signs to check serious ailments, have gained significant momentum.

U.S. ingestible sensors market, by sensor type, 2013 - 2024 (USD Million)

View summary of "Ingestible Sensors Market Analysis Report"  @ http://www.grandviewresearch.com/industry-analysis/ingestible-sensors-market

Further key findings from the study suggest:

The major market share is estimated to be dominated by the North America region due largely to the technological advancements and the pre-existing robust research and development base. The majority of the companies dominating the market has progressed in terms of designing and manufacturing of sensors and is at present focusing on refining the existent products.

The Asia Pacific region is set to grow at a steady pace due to the increasing adoption of ingestible sensors in hospitals and clinics. With a huge target population base in this region including the escalating geriatric patient count afflicted with chronic diseases, smart pill technology, such as ingestibles address the need for novel technology to incorporate minimally invasive procedures in the diagnostic process.

Temperature and image sensors are the major profit gainers among the ingestible sensors as they furnish accurate readings with respect to the body temperature and metabolic changes; hence, facilitating easy interpretation

The medical vertical is expected to be the highest gaining segment owing to the increasing adoption of ingestible sensors in patients, followed by the sports and fitness segments

Some key market players include Proteus Digital Health, Inc., CapsoVision, Inc., Given Imaging, Inc., and Olympus Corporation, among others.

Request for free sample of "Ingestible Sensors Market Analysis Report" @ http://www.grandviewresearch.com/industry-analysis/ingestible-sensors-market/request

[healthcareanalysis-blog]

Medical Image Analysis Software Market Growth, Analysis and Share to 2024

The medical image analysis software market is expected to reach USD 4.5 billion by 2024, according to a new report by Grand View Research, Inc. The clinical urgency to incorporate medical image analysis software for the diagnosis of chronic diseases is presumed to fuel the market growth throughout the forecast period. Moreover, the increased use of electronic health records to efficiently store, manage, and distribute patient health information in the form of medical images is also contributing towards the market growth.  Additionally, continuous advancements in the technology, such as computer-aided diagnosis (CAD) are expected to provide potential growth opportunities for the utilization of the new and improved medical image software tools in a wide range of disease application areas including cancer and urology.

The steady demand for diagnostic and treatment procedures with greater efficiency have consequentially boosted the industry share of the medical image analysis software tools with enhanced features. Improved image quality, high resolution, and multi-modal imaging platforms are the key associated benefits driving the physician preference, thereby fuelling the market demand. Furthermore, the incorporation of the software tools facilitates sharing of medical image records among physicians to facilitate rapid and accurate treatment delivery, thus the implied demand for the medical image analysis software systems. These aforementioned factors are expected to drive the emergence of the medical image analysis software market over the forecast period.

North America medical image analysis software market, by modality, 2013-2024 (USD Million)

View summary of "Medical Image Analysis Software Market Analysis Report"  @ http://www.grandviewresearch.com/industry-analysis/medical-image-analysis-software-market

Further key findings from the study suggest:

On the basis of software type, the stand-alone software segment is anticipated to grow at a lucrative CAGR of over 7.5% over the forecast period due largely to the associated benefits, such as the systems with a user-friendly interface in use, which eliminates the requirement of skilled workforce to operate these systems

In terms of modality, ultrasound imaging is expected to register a lucrative growth rate of over 8.9% in the coming eight years. According to a report by NCBI, the ultrasound imaging segment can detect around 92.5% of the breast lumps. Moreover, the use of high-frequency radiation is not involved, thus ensuring patient safety; the high diagnosis efficiency and patient safety factors are anticipated to further fuel this segment’s demand.

On the basis of applications, the cardiology segment is expected to register the fastest growth owing to the rising in corporation of medical imaging systems used for the diagnosis of cardiovascular diseases (CVDs), such as Merge Cardio, which integrates digital health records from various cardiology-based modalities thus furnishing cardiologists with comprehensive patient record files with additional features, such as remote location access, along with the high prevalence rate of the CVDs synergistically accelerating the growth of this segment.

Diagnostic centers are anticipated to grow at a lucrative CAGR amongst the end-use market segment as a consequence of the increasing number of imaging diagnostic labs and the government initiatives in this direction. For example, Moldovan Ministry of Health along with International Finance Corporation are trying to attract private sector investors through public-private partnerships to set up and modernize radiology and diagnostic imaging.

As of 2015, North America dominated the regional medical image analysis software market at over 33.0%as a result of the presence of leading industry players and the supportive reimbursement policies. The rising government funding directed towards improving the imaging facility is also a prime growth driver for this regional market.

Asia Pacific is expected to be growing at the fastest CAGR of over 9.0% during the forecast period due to the rising penetration of the medical imaging systems in fast emerging economies of the Asia pacific region, such as China and India, investments in the healthcare industry, high R&D intensity by the major market players, and the presence of untapped opportunities

Some key players catering to this industry are Philips Healthcare, Siemens Healthineers, Toshiba Medical Systems Corporation, ClaroNav, Inc., GE Healthcare, Agfa Gevaert Corporation, Spacelabs Healthcare, Inc., Aquilab GmbH, MIM Software, Inc., Merge Healthcare, Inc., Carestream Health, Inc., Esaote, Inc., Bruker Corporation, and Xinapse Systems Ltd.

These market players are adopting strategies, such as technological innovation, new product development, and strategic collaborations as well as mergers & acquisitions to maximize their industry share. In August 2015, GE Healthcare received an FDA approval for its low dose Computed Tomography for lung cancer screening thereby expanding its product portfolio.

Request for free sample of "Medical Image Analysis Software Market Analysis Report" @ http://www.grandviewresearch.com/industry-analysis/medical-image-analysis-software-market/request

[healthcareanalysis-blog]

In Vitro Diagnostics (IVD) Quality Control Market Analysis, Size and Growth to 2024

The global IVD quality control market is expected to reach over USD 1.13 billion by 2024 according to a new report by Grand View Research, Inc.

The continually evolving technology-oriented changes in the diagnostics field and the growing requirement to ensure patient safety necessitate the implementation of quality assurance programs in various medical disciplines including radiology and point-of-care devices.

The patients rely on self-testing IVD devices for long-term disease management and hence it is important for such IVD devices to be checked for quality in terms of result reproducibility and validity in order to guarantee patient safety. The rising number of certified clinical laboratories offering dependable IVD-based diagnostic services directly correlates with increased patient confidence, thus driving the quality control market.

In addition to quality assessments, amendments to the regulatory framework are made intermittently to enhance the present quality standards with the main objective of safeguarding qualitative superiority of the diagnostic services rendered to patients.

In May 2016, the European Union passed an agreement to update the pre-existing regulations pertaining to IVD devices wherein the updates were in concern with raising the patient safety levels, particularly for disabled persons. Furthermore, the presence of third party quality control agencies for independent assessment of the IVD devices is expected to elevate the current safety standards, which is expected to further propel the market growth.

U.S. IVD quality control market, by product, 2013 - 2024 (USD Million)

View summary of "In Vitro Diagnostics (IVD) Quality Control Market Analysis Report"  @ http://www.grandviewresearch.com/industry-analysis/in-vitro-diagnostics-ivd-quality-control-market

Further key findings from the study suggest:

In 2015, the clinical chemistry segment dominated the IVD quality control market with a share of over 35%. The increasing demand for preventive medicine and the rapid transformation of clinical laboratories into highly automated and efficient businesses are some of the factors for its large market share.

The molecular diagnostics is one of the fastest growing segments during the forecast period owing to the increasing technical complexity of molecular diagnostic testing coupled with the constant need for quality evaluation to ensure standards. The molecular diagnostics tests are of prime importance as the test outcomes enable healthcare practitioners make critical treatment decisions.

The hospital segment held the largest share in 2015 due to the presence of highly advanced technology-based devices, such as Next Generation Sequencing (NGS), mass spectrophotometry, and microarrays, and the rising applications of the optimized quality-control procedures

The North America contributed over 43% of the market share in 2015 attributable to the presence of over 150,000 registered diagnostics laboratories. The clinical laboratories are required to provide accurate results and maintain the accuracy standards in order to retain their license to operate.

Many pharmaceutical companies are implementing the new draft guidance enforced by the U.S. FDA for data integrity on current Good Manufacturing Practices (cGMP).It provides information in relation to establishing robust operating procedures and strong quality management systems, obtaining high-quality raw materials, investigating quality deviations, and maintaining reliable diagnostic laboratories.

Request for free sample of "In Vitro Diagnostics (IVD) Quality Control Market Analysis Report" @ http://www.grandviewresearch.com/industry-analysis/in-vitro-diagnostics-ivd-quality-control-market/request

[healthcareanalysis-blog]

Biologic Imaging Reagents Market Analysis, Competitive Strategies and Forecasts to 2020

Biologic imaging reagents refer to substances used by researchers or medical practitioners to conduct diagnostic or research based exercises. Biologic imaging reagents play a pivotal role in the field of healthcare and other life science industries. They provide significant assistance in the detection of biological processes at a molecular level. Moreover, these imaging reagents assist medical practitioners and physicians in obtaining diagnostic information for the detection and treatment of diseases especially in the field of cardiovascular, oncology and neurology.

The high prevalence of cardiovascular diseases, neurological diseases and cancer is the most important driving factor for this market. According to WHO, cardiovascular diseases is one of leading causes of death. This coupled with the rising patient awareness levels will drive the growth of this market by causing a rise in the number of diagnostic procedures. Moreover, growing demand for diagnostic imaging devices such as MRI and x-ray devices induced by the introduction of digital and portable systems and the implementation of PACS (picture archiving and communication systems) will cause a surge in the demand for biologic imaging reagents.

The contrast reagents market is further segmented into MRI reagents, ultrasound reagents and x-ray and CT reagents. This market is expected to lead the overall market in terms of share throughout the forecast period. High volume of diagnostic procedures performed using x-ray devices, ultrasound and MRI and rising popularity of these devices on account of growing demand for point of care diagnostics and home healthcare markets attribute to the aforementioned fact.

For more information on "Biologic Imaging Reagents Market Analysis” Visit: http://www.grandviewresearch.com/industry-analysis/biologic-imaging-reagents-industry

Grand View’s market research study takes a closer look at the biologic imaging reagents industry, providing a holistic perspective on market dynamics, patient preference and disease trends, supply and demand. Our report deep-dives into the market and segments it on multiple levels and providing key insights on a macro as well as micro environmental level. The study aims at providing granular information, regarding estimates and forecasts for key product segments including contrast reagents, radiopharmaceuticals and optical imaging reagents. The report analyzes the market for all the aforementioned product segments on a regional basis. Major geographies accounted for in this research study include North America, Europe and Asia-Pacific.

Grand View’s market research reports are developed using a 3600 methodology, which provides a balance between published authenticated data and exclusive primary research. We conduct exhaustive primary interviews with key industry participants, in order to enable readers to get a realistic feel of the industry pulse and facilitate decision making. Our unique excel-based reports not only provide key insights on the industry, but also quick and easy data access, with enhanced usability at minimum effort.

Grand View’s market research study attempts to provide insights to senior and top-level management, on critical industry questions such as the current and expected biologic imaging reagents global and regional supply-demand scene, drivers, restraints, opportunities and key trends in the market and how will these trends impact the market in coming years. Demand estimate and forecast for key product segments in the market, broken down by region have been provided in the study. The report also throws light on key industries for growth opportunities for biologic imaging reagent manufacturers and suppliers and the competitive landscape along with market presence of key participants.

Request TOC of “Biologic Imaging Reagents Market Analysis" visit : http://www.grandviewresearch.com/industry-analysis/biologic-imaging-reagents-industry/request-toc